(84 days)
The AOS Trochanteric Nail is intended to treat stable and unstable proximal fractures of the femur including pertrochanteric, intertrochanteric and high subtrochanteric fractures and combinations of these fractures. The long trochanteric nail is additionally indicated for subtrochanteric fractures, pertochanteric fractures associated with shaft fractures, pathologic fractures (including prophylactic use) in osteoporotic bone of the trochanteric and diaphyseal areas, long subtrochanteric fracture, insilateral femoral fractures, proximal and distal non-unions and malunions and revisions procedures.
The AOS Trochanteric Nail is femoral intramedullary nail that is design to enter through the greater trochanter. It consists of an intramedullary nail, sliding lag screw, anti-rotation screws and end cap. The Trochanteric Nail is a cannulated nail with proximal diameter of 15mm. The short Trochanteric Nails are18cm in length and the long Trochanteric Nails are 30cm, 36cm and 42cm in length. The nails are produced in diameters of 9mm, and 11mm. The proximal end of the nail has two holes; one to accept the 11mm lag screw and one to accept the optional 5.0mm anti-rotation screw. There are two nail configurations with the proximal holes angled at 125° or 130°. The proximal holes in the long nails having 10° of anteversion and are in a left and a right configuration. The proximal end of the nail is threaded to accept an end can. The distal end of the nail contains one cross locking hole and one cross locking slot. The distal hole and the slot are design to accept 5.0mm screws.
The provided text is a 510(k) summary for the AOS Trochanteric Nail, an intramedullary fixation rod for treating femoral fractures. This document focuses on demonstrating substantial equivalence to previously marketed devices rather than presenting a study with acceptance criteria and device performance metrics in the way a clinical trial for a diagnostic device would.
Therefore, the requested information components related to acceptance criteria, device performance, sample sizes, expert ground truth, adjudication methods, MRMC studies, standalone performance, and ground truth for training sets are not applicable (N/A) in this context.
This 510(k) summary is for a Class II medical device (intramedullary fixation rod) and relies on demonstrating an equivalence to legally marketed predicate devices, not on a performance study against specific acceptance criteria.
Summary of available information:
-
A table of acceptance criteria and the reported device performance:
- N/A. The document is a 510(k) summary for a medical device seeking market clearance based on substantial equivalence, not a performance study with explicit acceptance criteria. The "performance" is implicitly demonstrated through comparison to predicate devices' design and intended use.
-
Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):
- N/A. No test set or clinical data is presented for performance evaluation in this 510(k) summary.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):
- N/A. No ground truth establishment by experts is mentioned, as there is no specific performance study.
-
Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- N/A. No adjudication method is mentioned, as there is no specific performance study.
-
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- N/A. This device is a physical implant (intramedullary nail), not an AI-powered diagnostic tool, so an MRMC study is irrelevant.
-
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- N/A. This is a physical medical device, not an algorithm.
-
The type of ground truth used (expert concensus, pathology, outcomes data, etc):
- N/A. No performance study necessitating ground truth is presented.
-
The sample size for the training set:
- N/A. Not a machine learning or AI device.
-
How the ground truth for the training set was established:
- N/A. Not a machine learning or AI device.
Key information from the document that is relevant:
- Device Name: AOS Trochanteric Nail
- Intended Use: To treat stable and unstable proximal fractures of the femur (pertrochanteric, intertrochanteric, high subtrochanteric, combinations) and, for the long nail, subtrochanteric fractures, pertrochanteric fractures with shaft fractures, pathologic fractures (prophylactic use) in osteoporotic bone, long subtrochanteric fracture, insilateral femoral fractures, proximal and distal non-unions and malunions, and revision procedures.
- Device Description: A femoral intramedullary nail designed to enter through the greater trochanter, consisting of an intramedullary nail, sliding lag screw, anti-rotation screws, and end cap. It is cannulated with various lengths (18cm for short, 30cm, 36cm, 42cm for long) and diameters (9mm, 11mm).
- Substantial Equivalence Rationales: The device was shown to be substantially equivalent to the following predicate devices:
- Regulatory Class: Class II
- Product Code: HSB (Intramedullary fixation rod)
{0}------------------------------------------------
JUN 2 0 2002
510(k) SUMMARY
| NAME OF FIRM: | Advanced Orthopaedic Solutions |
|---|---|
| 510(k) CONTACT PERSON: | Paul DonerVice President Operations and Regulatory |
| TRADE NAME: | AOS Trochanteric Nail |
| COMMON NAME: | Intramedullary Fixation Rod |
| CLASSIFICATION: | 888.3020 Intramedullary Fixation Rod. |
| DEVICE CODE: | HSB |
| SUBSTANTIALLY EQUIVALENT DEVICE: | DePuy Ace, Trochanteric Nail & Long Trochanteric Nail;Howmedica, Gamma Nail & Trochanteric Dyax Nail; Smith andNephew, Intramedullary Hip Screw |
INTENDED USE:
The AOS Trochanteric Nail is intended to treat stable proximal fractures of the femur including pertrochanteric interic and high subtrochanteric fractures and combinations of these fractures. The long trochanteric nail is additionally indicated for subtrochanteric fractures, pertochanteric fractures associated with shaft fractures pathologic fractures (including prophylactic use) in osteoporotic bone of the trochanteric and diaphyseal areas, long subtrochanteric fracture, insilateral fractures, proximal and distal non-unions and malunions and revisions procedures.
DEVICE DESCRIPTION AND SUBSTANTIAL EQUIVALENCE RATIONALES:
The AOS Trochanteric Nail is femoral intramedullary nail that is design to enter through the greater trochanter. It consists of an intramedullary nail, sliding lag screw, anti-rotation screws and end cap.
The Trochanteric Nail is a cannulated nail with proximal diameter of 15mm. The short Trochanteric Nails are18cm in length and the long Trochanteric Nails are 30cm, 36cm and 42cm in length. The nails are produced in diameters of 9mm, and 11mm. The proximal end of the nail has two holes; one to accept the 11mm lag screw and one to accept the optional 5.0mm anti-rotation screw. There are two nail configurations with the proximal holes angled at 125° or 130°. The proximal holes in the long nails having 10° of anteversion and are in a left and a right configuration. The proximal end of the nail is threaded to accept an end can.
The distal end of the nail contains one cross locking hole and one cross locking slot. The distal hole and the slot are design to accept 5.0mm screws.
The AOS Trochanteric Nail was shown to be substantially equivalent to the following devices.
| DePuy ACE, Trochanteric Nails | K010780 and K013563 |
|---|---|
| Howmedica Osteonics, Gamma Nails | K993670, K012158 and K013524 |
| Smith and Nephew, Intramedullary Hip Screw | K 912162, K921786 and K954712 |
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines representing its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 2 0 2002
Mr. Paul Doner Vice President Operations and Regulatory Advanced Orthopaedic Solotions 333 W. 6th Street, Suite 202 San Pedro. CA 90731
Re: K021008
Trade/Device Name: Advanced Orthopaedic Solutions Trochanteric Nail Regulatory Number: 888.3020 Regulatory Name: Intramedullary fixation rod Regulatory Class: II Product Code: HSB Dated: March 27, 2002 Received: March 28, 2002
Dear Mr. Doner:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{2}------------------------------------------------
Page 2 - Mr. Paul Doner
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
for Mark N Milliken
Celia Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
510(k) Number (if known)
Advanced Orthopaedic Solutions Trochanteric Nail Device Name:
KO21008
. Indications for Use:
The AOS Trochanteric Nail is intended to treat stable and unstable proximal fractures of the femur including pertrochanteric, intertrochanteric and high subtrochanteric fractures and combinations of these fractures. The long trochanteric nail is additionally indicated for subtrochanteric fractures, pertochanteric fractures associated with shaft fractures, pathologic fractures (including prophylactic use) in osteoporotic bone of the trochanteric and diaphyseal areas, long subtrochanteric fracture, insilateral femoral fractures, proximal and distal non-unions and malunions and revisions procedures.
Concurrence of CDRH, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109) OR
- 1 -
Over-The-Counter
Mark N Miller
(Division Sign-Off) Division of General, Restorative and Neurological Devices
510(k) Number.
§ 888.3020 Intramedullary fixation rod.
(a)
Identification. An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.(b)
Classification. Class II.